| Pharmaceutical active ingredients: |
| Trimetazidine Hydrochloride |
| Available forms, composition and doses of Trimetazidine: |
| Solution; Oral; Trimetazidine Hydrochloride 20 mg / mlTablets, Film-Coated; Oral; Trimetazidine Hydrochloride 20 mg |
| Trimetazidine medical category: |
| Human:Anti-anginal drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01EB15 - Trimetazidine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Trilufen | Pseudoephedrine Hydrochloride; Terfenadine | Sanofi-Aventis |
| Trimebutine | Trimebutine Maleate | Sanofi-Aventis |
| Trimed | Sulfametopyrazine; Trimethoprim | Sanofi-Aventis |
| Trimepranol | Metipranolol; Metipranolol Fumarate | Sanofi-Aventis; Zentiva |
| Trimesuxol | Sulfamethoxazole; Trimethoprim | Sanofi-Aventis |
| Trimexazol | Sulfamethoxazole; Trimethoprim | Sanofi-Aventis; ICN Pharmaceuticals; Valeant Pharmaceuticals |
| Trimexazol Balsamico | Ammonium Chloride; Guaifenesin; Sulfamethoxazole; Trimethoprim | Sanofi-Aventis |
| Trimexazol F | Sulfamethoxazole; Trimethoprim | Sanofi-Aventis; ICN Pharmaceuticals; Valeant Pharmaceuticals |
| Trimexazol Forte | Sulfamethoxazole; Trimethoprim | Sanofi-Aventis; ICN Pharmaceuticals; Valeant Pharmaceuticals |
| Trimexazole | Sulfamethoxazole; Trimethoprim | Sanofi-Aventis; CCM Pharmaceuticals; Central Poly Trading; Pharmasant Laboratories; Upha Corporation |